Health Trials

HGBL With MYC and BCL2 and/or BCL6 Rearrangements

2

Review clinical trials related to HGBL With MYC and BCL2 and/or BCL6 Rearrangements. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

SynKIR-310 for Relapsed/Refractory B-NHL

This first-in-human (FIH) trial is designed to assess the safety, feasibility and preliminary efficacy of a single intravenous (IV) dose of SynKIR-310 administered to participants with relapsed/refractory B-NHL.

Participants needed: 36
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Verismo TherapeuticsUpdated: Apr 14, 2026Locations: 5
Eligibility criteria

Adult 18 years of age and older. [+7]

Previously treated with any investigational agent within 30 days prior to screen... [+5]

Read more
Status: Recruiting

Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma

This study is to investigate the safety and tolerability of C402-CD19-CAR treatment in subjects with relapsed or refractory large B-cell lymphoma and further determine the recommended Phase 2 dose of C402-CD19-CAR.

Participants needed: 18
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai Exuma Biotechnology Ltd.Updated: Jun 13, 2025Locations: 1
Eligibility criteria

Male or female 18-75 years (inclusive); [+15]

History of receiving allogeneic hematopoietic stem cell transplantation, adoptiv... [+14]

Read more